Antiretroviral Therapy in Special Populations With HIV: A Wheel of Knowledge Challenge!

0.50 CME
0.50 CPE
30 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Antiretroviral Therapy in Special Populations with HIV: A Wheel of Knowledge Challenge!

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Merck & Co., Inc.


Activity Description

Antiretroviral therapy has improved dramatically over the past decade. This progress has yielded more treatment choices for clinicians and patients but also adds greater complexity to the already diverse field of HIV treatment. Clinicians must keep apprised of new data regarding treatment strategies, including selection of appropriate individualized therapy and effective management of treatment side effects. In this Wheel of Knowledge interactive activity, your knowledge will be tested on the latest clinical developments and management strategies for patients with HIV, as expert faculty members provide guidance on how to incorporate new treatment strategies into clinical practice. Your hosts will also discuss various aspects of HIV management, including selecting antiretroviral treatment for patients presenting with HIV with comorbidities and/or metabolic complications, treatment of special populations with HIV, as well as individualizing therapy due to adverse effects and drug–drug interactions.


Target Audience

The intended audience for this activity is infectious disease specialists, internists, pharmacists, and other health care professionals involved in the management of patients with HIV.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Recognize special populations with HIV that are at risk for suboptimal treatment outcomes.
  • Utilize antiretroviral treatment regimens that reduce adverse effects and drug-drug interactions in special populations with HIV.
  • Incorporate the latest evidence into practice when selecting antiretroviral treatment for patients presenting with HIV, comorbidities, and/or metabolic complications.

Faculty

Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

David A. Wohl, MD
Professor of Medicine
Division of Infectious Diseases
University of North Carolina at
Chapel Hill School of Medicine
Chapel Hill, NC


Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Vindico  Medical Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

abimSuccessful completion of this CME activity enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in will earn MOC points equivalent to the amount of CME credits claimed for the activity.

This program is acceptable for 0.5 contact hour of Accreditation Council for Pharmacy Education (ACPE) Continuing Education Credit. The ACPE Universal Program Number is 0482-0000-21-028-H02-P , effective 11/15/2021 . This is a knowledge-based activity and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information directly to the ACPE through CPE Monitor within 30 days.

This enduring material is approved for 1 year from the date of original release, November 15, 2021 to November 14, 2022.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 75% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Faculty report the following relationship(s)

Richard A. Elion, MD
Advisor: Gilead, Merck, ViiV
Consultant: Gilead, ViiV
Speaker for Ineligible Company: Gilead, ViiV
Advisory Board: Trio Health

David A. Wohl, MD
Consultant: Gilead, Janssen, Merck, ViiV
Independent Research Contractor: Gilead, Merck, ViiV
Fees for Non-CE Services Received Directly from a Commercial Interest or its Agent: Gilead, Viiv

Reviewers report the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Cocohoba, PharmD, MAS, BCPS, AAHIVP
Independent Research Contractor: Actelion/Janssen, Genentech, ViiV, Walgreens

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com